A not-for-profit organisation
committed to injured people
A not-for-profit organisation
committed to injured people

Sarah Moore

Sarah’s practice focuses primarily on product liability and environmental litigation, essentially involving personal injury group actions.


Sarah commenced her career at Freshfields Bruckhaus Deringer where she trained in both their London and Paris offices. Most recently, she practiced as an associate solicitor at Leigh Day in London, where she was involved in high profile litigation against British corporations concerning a range of product liability and environmental issues. Her cases have involved defective medical devices, pharmaceuticals and mass torts-often committed overseas by UK multinationals.

She joins Hausfeld as a partner to expand our human rights and environmental disputes practice, with her broad range of experience also complimenting our group actions and consumer claims work.  


Throughout her career in the legal industry, her clients mainly consist of charities and large groups of individuals due to the nature of her practice.

Product liability

At Hausfeld, Sarah is:

  • Acting for a group of bereaved and injured individuals affected by Vaccine Induced Thrombocytic Thrombocytopenia (VITT) linked with the Vaxzevria COVID19 vaccination.
  • Acting for an individual client against breast implant manufacturer Allergan Limited, in relation to her diagnosis of Breast Implant Associated- Anaplastic Large Cell Lymphoma (BIA-ALCL).
  • Advising campaign group VIBUK in their advocacy work seeking urgent reform of the outdated Vaccine Damage Payment Act and related Vaccine Damage Payment Scheme.

Prior to joining Hausfeld, Sarah was a member of the legal teams which:

  • Acted on behalf of a group of UK based individuals with Thalidomide related injuries who had been excluded from the Thalidomide Trust.
  • Acted on behalf of a group of 300 individuals, in Gee v. Depuy International Limited (a subsidiary of Johnson and Johnson) in the Pinnacle Metal on Metal Hip Litigation.
  • Acted on behalf of a group of women implanted with prosthetic breast implants who had developed BIA-ALCL causally linked to their breast implants.
  • Acted on behalf of charities working with families affected by Foetal Valproate Syndrome (FVS) in making submissions to the IMMDS Review led by Baroness Cumberlege.
  • Acted on behalf of the Vaccine Victims’ Support Group (VVSG) to seek reform of the Vaccine Damage Payment Act and/or fuller compensation for those injured as a result of DTP vaccination pre-2003.